Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation

Abstract Background: Atrial fibrillation (AF) is the most common complication after coronary artery bypass graft surgery (CABG). This complication causes an increase in morbidity and mortality after CABG and also increases the length of ICU stay and hospitalization. The aim of this study is to eval...

Full description

Bibliographic Details
Main Authors: Niloofar Dadashpour, Esmaeel Moshiri, Ali Reza Kamali, Ali Reza Rostami, Majid Golestani Eraghi
Format: Article
Language:fas
Published: Arak Medical University 2015-06-01
Series:Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
Subjects:
Online Access:http://amuj.arakmu.ac.ir/article-1-3717-en.pdf
_version_ 1818211081390129152
author Niloofar Dadashpour
Esmaeel Moshiri
Ali Reza Kamali
Ali Reza Rostami
Majid Golestani Eraghi
author_facet Niloofar Dadashpour
Esmaeel Moshiri
Ali Reza Kamali
Ali Reza Rostami
Majid Golestani Eraghi
author_sort Niloofar Dadashpour
collection DOAJ
description Abstract Background: Atrial fibrillation (AF) is the most common complication after coronary artery bypass graft surgery (CABG). This complication causes an increase in morbidity and mortality after CABG and also increases the length of ICU stay and hospitalization. The aim of this study is to evaluate the prophylactic effect of amiodarone in reducing the incidence of post CABG atrial fibrillation. Materials and Methods: In this clinical trial study, 204 patients, candidate for elective CABG, entered the study according to inclusion and exclusion criteria, and randomly divided into two equal groups. The case group received 300 mg of intravenous amiodarone before anesthesia induction and the control group received normal saline. Incidence of AF was recorded until 24 hours after CABG. Results: The incidence of post CABG AF was 16 patients in the case group and 35 patients in the control group. Comparison of the frequency of AF between groups by Chi square analyses showed a significant difference (p=0.037) and the incidence of AF was significantly lower in the amiodarone group. Conclusion: In total, amiodarone could significantly prevent the incidence of atrial fibrillation after coronary artery bypass surgery. In this study, patients took this medication only in the first 24 hours, while in some studies, this drug has been prescribed for even 14 days.
first_indexed 2024-12-12T05:26:50Z
format Article
id doaj.art-61a61ab2e56d4a3f8580d0a2cc051bf4
institution Directory Open Access Journal
issn 1735-5338
2008-644X
language fas
last_indexed 2024-12-12T05:26:50Z
publishDate 2015-06-01
publisher Arak Medical University
record_format Article
series Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
spelling doaj.art-61a61ab2e56d4a3f8580d0a2cc051bf42022-12-22T00:36:27ZfasArak Medical UniversityMajallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk1735-53382008-644X2015-06-011831927Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial FibrillationNiloofar Dadashpour0Esmaeel Moshiri1Ali Reza Kamali2Ali Reza Rostami3Majid Golestani Eraghi4Arak University of Medical Sciences, Arak, IranDepartment of Anesthesiology, Arak University of Medical Sciences, Arak, IranDepartment of Anesthesiology, Arak University of Medical Sciences, Arak, IranDepartment of Cardiac Surgery, Arak University of Medical Sciences, Arak, IranDepartment of Internal Medicine, Arak University of Medical Sciences, Arak, IranAbstract Background: Atrial fibrillation (AF) is the most common complication after coronary artery bypass graft surgery (CABG). This complication causes an increase in morbidity and mortality after CABG and also increases the length of ICU stay and hospitalization. The aim of this study is to evaluate the prophylactic effect of amiodarone in reducing the incidence of post CABG atrial fibrillation. Materials and Methods: In this clinical trial study, 204 patients, candidate for elective CABG, entered the study according to inclusion and exclusion criteria, and randomly divided into two equal groups. The case group received 300 mg of intravenous amiodarone before anesthesia induction and the control group received normal saline. Incidence of AF was recorded until 24 hours after CABG. Results: The incidence of post CABG AF was 16 patients in the case group and 35 patients in the control group. Comparison of the frequency of AF between groups by Chi square analyses showed a significant difference (p=0.037) and the incidence of AF was significantly lower in the amiodarone group. Conclusion: In total, amiodarone could significantly prevent the incidence of atrial fibrillation after coronary artery bypass surgery. In this study, patients took this medication only in the first 24 hours, while in some studies, this drug has been prescribed for even 14 days.http://amuj.arakmu.ac.ir/article-1-3717-en.pdfAmiodaroneAtrial fibrillationCoronary artery bypass
spellingShingle Niloofar Dadashpour
Esmaeel Moshiri
Ali Reza Kamali
Ali Reza Rostami
Majid Golestani Eraghi
Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
Amiodarone
Atrial fibrillation
Coronary artery bypass
title Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
title_full Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
title_fullStr Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
title_full_unstemmed Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
title_short Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
title_sort evaluation of the prophylactic effect of amiodarone in reducing the incidence of post cabg atrial fibrillation
topic Amiodarone
Atrial fibrillation
Coronary artery bypass
url http://amuj.arakmu.ac.ir/article-1-3717-en.pdf
work_keys_str_mv AT niloofardadashpour evaluationoftheprophylacticeffectofamiodaroneinreducingtheincidenceofpostcabgatrialfibrillation
AT esmaeelmoshiri evaluationoftheprophylacticeffectofamiodaroneinreducingtheincidenceofpostcabgatrialfibrillation
AT alirezakamali evaluationoftheprophylacticeffectofamiodaroneinreducingtheincidenceofpostcabgatrialfibrillation
AT alirezarostami evaluationoftheprophylacticeffectofamiodaroneinreducingtheincidenceofpostcabgatrialfibrillation
AT majidgolestanieraghi evaluationoftheprophylacticeffectofamiodaroneinreducingtheincidenceofpostcabgatrialfibrillation